Your browser doesn't support javascript.
loading
TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation.
Chiramel, Abhilash I; Meyerson, Nicholas R; McNally, Kristin L; Broeckel, Rebecca M; Montoya, Vanessa R; Méndez-Solís, Omayra; Robertson, Shelly J; Sturdevant, Gail L; Lubick, Kirk J; Nair, Vinod; Youseff, Brian H; Ireland, Robin M; Bosio, Catharine M; Kim, Kyusik; Luban, Jeremy; Hirsch, Vanessa M; Taylor, R Travis; Bouamr, Fadila; Sawyer, Sara L; Best, Sonja M.
Afiliação
  • Chiramel AI; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA.
  • Meyerson NR; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309, USA.
  • McNally KL; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA.
  • Broeckel RM; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA.
  • Montoya VR; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA.
  • Méndez-Solís O; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA.
  • Robertson SJ; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA.
  • Sturdevant GL; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA.
  • Lubick KJ; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA.
  • Nair V; Research Technology Branch, RML, NIAID, NIH, Hamilton, MT 59840, USA.
  • Youseff BH; Department of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo Health Science Campus, Toledo, OH 43606, USA.
  • Ireland RM; Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, RML, NIAID, NIH, Hamilton, MT 59840, USA.
  • Bosio CM; Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, RML, NIAID, NIH, Hamilton, MT 59840, USA.
  • Kim K; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
  • Luban J; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
  • Hirsch VM; Laboratory of Molecular Microbiology, NIAID, Bethesda, MD 20892, USA.
  • Taylor RT; Department of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo Health Science Campus, Toledo, OH 43606, USA.
  • Bouamr F; Laboratory of Molecular Microbiology, NIAID, Bethesda, MD 20892, USA.
  • Sawyer SL; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309, USA.
  • Best SM; Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT 59840, USA. Electronic address: sbest@niaid.nih.gov.
Cell Rep ; 27(11): 3269-3283.e6, 2019 06 11.
Article em En | MEDLINE | ID: mdl-31189110
ABSTRACT
Tripartite motif-containing protein 5α (TRIM5α) is a cellular antiviral restriction factor that prevents early events in retrovirus replication. The activity of TRIM5α is thought to be limited to retroviruses as a result of highly specific interactions with capsid lattices. In contrast to this current understanding, we show that both human and rhesus macaque TRIM5α suppress replication of specific flaviviruses. Multiple viruses in the tick-borne encephalitis complex are sensitive to TRIM5α-dependent restriction, but mosquito-borne flaviviruses, including yellow fever, dengue, and Zika viruses, are resistant. TRIM5α suppresses replication by binding to the viral protease NS2B/3 to promote its K48-linked ubiquitination and proteasomal degradation. Importantly, TRIM5α contributes to the antiviral function of IFN-I against sensitive flaviviruses in human cells. Thus, TRIM5α possesses remarkable plasticity in the recognition of diverse virus families, with the potential to influence human susceptibility to emerging flaviviruses of global concern.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeo Hidrolases / Proteínas Virais / Replicação Viral / Infecções por Flavivirus / Ubiquitina-Proteína Ligases / Complexo de Endopeptidases do Proteassoma / Proteínas com Motivo Tripartido Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeo Hidrolases / Proteínas Virais / Replicação Viral / Infecções por Flavivirus / Ubiquitina-Proteína Ligases / Complexo de Endopeptidases do Proteassoma / Proteínas com Motivo Tripartido Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos